Holen Sie sich die Stockscreener-App
0.7484
3.06%
0.0222
Handel nachbörslich:
.78
0.0316
+4.22%
Mdxhealth Sa Aktie (MDXH) Neueste Nachrichten
MDxHealth Files 2026 Interim Report as Losses Deepen but Fresh Capital Extends Runway - TipRanks
MDxHealth (MDXH) Stock Sees Fair Value Cut As Analysts Weigh Dilution And Execution - Yahoo Finance
MDxHealth (Nasdaq: MDXH) faces going-concern doubts after interim loss - Stock Titan
MDxHealth (MDXH) Holds Steady Near $0.72 as Consolidation Persists Between Key LevelsLarge Cap Trends - dars.gov.et
MDxHealth stock extends strong August rally after beating Q2 revenue expectations - AD HOC NEWS
MDxHealth SAADR Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
MDxHealth’s Revenue Growth Is Real, but the Margin Story Still Needs Work - AlphaStreet
MDxHealth (MDXH) Momentum: Finishes 3.19% Up at $0.74 for the Current Session; Chart Watch - dars.gov.et
MDXH Maintained by BTIG -- Price Target Lowered to $2.00 - GuruFocus
MDxHealth price target lowered to $2 from $4 at BTIG - TipRanks
BTIG cuts MDxHealth stock price target on higher share count - Investing.com
MDxHealth SA (MDXH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MDxHealth revenue up 16% in Q2, stock surges on guidance affirmation - scanx.trade
MDxHealth (MDXH) Q2 2026 Earnings Call Transcript - The Globe and Mail
MDxHealth (MDXH) Chart: Records a 5.15% Decrease to $0.72; Key Range: the Current Price Sits Inside the Supplied Technical Range on the DayFibonacci Extension - dars.gov.et
MDxHealth (MDXH) Earnings Reading: Reported EPS Tops Expectations for the Current Session; Share Move - vinanet.vn
MDxHealth (MDXH) Earnings Update: EPS Prints Above Forecast in Latest Trading; Post-Report: The Stock Ends Down 12.20% in the Available RecordTech Earnings Analysis - dars.gov.et
MDxHealth (MDXH) investors reveal 19.5% and 12.1% stakes - Stock Titan
MDxHealth (MDXH) Surges 4.58% to $0.84, Approaching Key Resistance at $0.88Cumulative Volume - vinanet.vn
MDxHealth (MDXH) Surges 74.89% to $0.81 as Momentum Builds in Diagnostic OncologyTime Weighted Price - vinanet.vn
MDxHealth (MDXH) Skyrockets 74.9% to $0.81: Key Levels to Watch After Explosive MoveLast Point Resistance - vinanet.vn
MDxHealth price target lowered to $3 from $5 at Lake Street - TipRanks
12 Health Care Stocks Moving In Friday's Intraday Session - Sahm
MDxHealth Says Well-Positioned to 'Return to Positive EBITDA' - Sahm
MDxHealth (MDXH) Q2 2026 Earnings Call: Umsatz erholt sich, Prognose bestätigt - TradingKey
Mdxhealth S.A. Earnings Call Shows Growth, Strain - TipRanks
MDXH Maintained by Lake Street -- Price Target Lowered to $3.00 - GuruFocus
Bleichroeder LP Discloses Investment at MDxHealth SA with 33.2% Stake - TradingView
MDxHealth SA Stock 12‑Month Price Target Cut to $2.2, Implies 376% Upside - TradingView
Bleichroeder (MDXH) reports 31.6M-share, 33.2% holding in MDxHealth - Stock Titan
MDxHealth SA Stock 12‑Month Price Target Cut to $2.6, Implies 463% Upside - TradingView
MDxHealth S.A. Q2 2026 Earnings Call Summary - Yahoo Finance
Conferencia de resultados del T2 de 2026 de MDxHealth (MDXH): los ingresos se recuperan, se mantienen las previsiones - TradingKey
MDxHealth (MDXH) Q2 2026 Earnings Call: Revenue Rebounds, Guidance Maintained - TradingKey
MDxHealth SA (MDXH) (Q2 2026) Earnings Call Highlights: Record S - GuruFocus
MDxHealth SA (MDXH) (Q2 2026) Earnings Call Highlights: Record Sequential Growth and Strategic ... - finance.yahoo.com
Earnings call transcript: MDxHealth tops revenue estimates in Q2 2026 By Investing.com - Investing.com Canada
MDXH Looks 79.0% Undervalued on GF Value™ but Faces Value Trap W - GuruFocus
Earnings call transcript: MDxHealth tops revenue estimates in Q2 2026 - Investing.com
MDxHealth SA (MDXH) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Full Transcript: MDxHealth Q2 2026 Earnings Call - Benzinga
MDxHealth SA reports results for the quarter ended June 30Earnings Summary - TradingView
MDxHealth Raises $20 Million in Direct Share Offering and Amends Articles After Capital Increase - TipRanks
MDxHealth Posts Q2 2026 Revenue Growth, Exits Resolve Business and Raises $20 Million - TipRanks
MDxHealth ADR earnings missed, revenue topped estimates - Investing.com
MDXHEALTH SA ($MDXH) Releases Q2 2026 Earnings - Quiver Quantitative
Mdxhealth Reports Second Quarter 2026 Financial Results - The Manila Times
MDxHealth (MDXH) sells 44M shares, lifting total stock to 95.4M - Stock Titan
MDxHealth (NASDAQ: MDXH) lifts Q2 2026 revenue 16% but posts deeper loss - Stock Titan
Mdxhealth Sells 44M Shares for $20M Gross as Q2 Net Loss Hits $9.5M - Stock Titan
MDxHealth (MDXH) investor Laurence Lytton discloses 9.6% beneficial ownership - Stock Titan
MDxHealth SA (MDXH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Mdxhealth to Release Second Quarter 2026 Financial Results on August 13 - The Manila Times
Mdxhealth schedules live Q&A on second-quarter results Aug. 13 - Stock Titan
MDxHealth SA (MDXH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MDXH|MDxHealth SA|Price:0.410|Chg%:-0.012 - TradingKey
MDxHealth SA (MDXH) Cash Flow - TradingKey
MDxHealth SA Revenue Breakdown – NASDAQ:MDXH - TradingView
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency - The Manila Times
MDXH Faces Nasdaq Compliance Challenge with Market Value Below $35M - GuruFocus
MDxHealth Faces New Nasdaq Warning Over Market Value Shortfall - TipRanks
Mdxhealth (NASDAQ: MDXH) warned on US$35M Nasdaq market value rule - Stock Titan
mdxhealth Receives Nasdaq Notice of Minimum Market Value Deficiency - Quiver Quantitative
Mdxhealth Has Until Jan. 19 to Regain Compliance or May Face Delisting - Stock Titan
1.39%
1.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):